Cryotherapy Market

Executive Summary

Cryotherapy Market was valued at US $269.66 million in 2021 and is projected to grow at 9.26% CAGR over the forecast period to reach US $458.85 million by 2027. Cryotherapy Market represented US $43.79 million opportunity over 2019-2021 and estimated to create US $189.19 million opportunity in 2027 over 2021.

Cryotherapy from Consainsights analyses the Cryotherapy Market in the Life Sciences industry over the forecast period to 2027.

Cryotherapy research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Cryotherapy segmentation includes Product, Application, End User, Region and Geography.

Based on the Product, the Cryotherapy analysis covers Cryosurgery Devices, Localized Cryotherapy Devices, Cryochambers & Cryosaunas.

In Product segment, Cryosurgery Devices segment has highest cagr growth of 8.19%.

Based on the Application, the Cryotherapy analysis covers Surgical Applications, Pain Management, Recovery, Health, And Beauty.

In Application segment, Surgical Applications segment has highest cagr growth of 8.19%.

Based on the End User, the Cryotherapy analysis covers Hospitals & Specialty Clinics, Cryotherapy Centers, Spas & Fitness Centers.

In End User segment, Hospitals & Specialty Clinics segment has highest cagr growth of 8.19%.

Based on the Region, the Cryotherapy analysis covers North America, Europe, Asia Pacific, Rest of the World (Row).

In Region segment, North America segment has highest cagr growth of 8.19%.

Based on the region, the Cryotherapy analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include Medtronic, Impact Cryotherapy, Zimmer Medizinsysteme, Metrum Cryoflex, Brymill Cryogenic Systems, Cryoconcepts Lp, Kriosystem Life, Us Cryotherapy, Galil Medical (A Subsidiary of Btg Plc), Coopersurgical (A Subsidiary of the Cooper Companies), Professional Products, Erbe Elektromedizin and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Product

Introduction

In 2021, Cryosurgery Devices segment has the highest revenue of US $137.03 million and is expected to grow at CAGR of 8.19% by 2027 Cryosurgery Devices segment has highest cagr growth of 8.19%.

Cryosurgery Devices

Cryosurgery Devices segment was valued at US $114.78 million in 2019 and is projected to grow at 8.19% CAGR over the forecast period to reach US $233.17 million by 2027. Cryosurgery Devices segment represented US $22.25 million opportunity over 2019-2021 and estimated to create US $96.14 million opportunity in 2027 over 2021.

Localized Cryotherapy Devices

Localized Cryotherapy Devices segment was valued at US $68.33 million in 2019 and is projected to grow at 8.19% CAGR over the forecast period to reach US $138.81 million by 2027. Localized Cryotherapy Devices segment represented US $13.25 million opportunity over 2019-2021 and estimated to create US $57.23 million opportunity in 2027 over 2021.

Cryochambers & Cryosaunas

Cryochambers & Cryosaunas segment was valued at US $42.76 million in 2019 and is projected to grow at 8.19% CAGR over the forecast period to reach US $86.87 million by 2027. Cryochambers & Cryosaunas segment represented US $8.29 million opportunity over 2019-2021 and estimated to create US $35.82 million opportunity in 2027 over 2021.

Application

Introduction

In 2021, Surgical Applications segment has the highest revenue of US $135.88 million and is expected to grow at CAGR of 8.19% by 2027 Surgical Applications segment has highest cagr growth of 8.19%.

Surgical Applications

Surgical Applications segment was valued at US $113.81 million in 2019 and is projected to grow at 8.19% CAGR over the forecast period to reach US $231.20 million by 2027. Surgical Applications segment represented US $22.06 million opportunity over 2019-2021 and estimated to create US $95.33 million opportunity in 2027 over 2021.

Pain Management

Pain Management segment was valued at US $78.99 million in 2019 and is projected to grow at 8.19% CAGR over the forecast period to reach US $160.46 million by 2027. Pain Management segment represented US $15.31 million opportunity over 2019-2021 and estimated to create US $66.16 million opportunity in 2027 over 2021.

Recovery, Health, And Beauty

Recovery, Health, And Beauty segment was valued at US $33.07 million in 2019 and is projected to grow at 8.19% CAGR over the forecast period to reach US $67.19 million by 2027. Recovery, Health, And Beauty segment represented US $6.41 million opportunity over 2019-2021 and estimated to create US $27.70 million opportunity in 2027 over 2021.

End User

Introduction

In 2021, Hospitals & Specialty Clinics segment has the highest revenue of US $125.20 million and is expected to grow at CAGR of 8.19% by 2027 Hospitals & Specialty Clinics segment has highest cagr growth of 8.19%.

Hospitals & Specialty Clinics

Hospitals & Specialty Clinics segment was valued at US $104.87 million in 2019 and is projected to grow at 8.19% CAGR over the forecast period to reach US $213.04 million by 2027. Hospitals & Specialty Clinics segment represented US $20.33 million opportunity over 2019-2021 and estimated to create US $87.84 million opportunity in 2027 over 2021.

Cryotherapy Centers

Cryotherapy Centers segment was valued at US $68.26 million in 2019 and is projected to grow at 8.19% CAGR over the forecast period to reach US $138.67 million by 2027. Cryotherapy Centers segment represented US $13.23 million opportunity over 2019-2021 and estimated to create US $57.18 million opportunity in 2027 over 2021.

Spas & Fitness Centers

Spas & Fitness Centers segment was valued at US $52.74 million in 2019 and is projected to grow at 8.19% CAGR over the forecast period to reach US $107.13 million by 2027. Spas & Fitness Centers segment represented US $10.22 million opportunity over 2019-2021 and estimated to create US $44.17 million opportunity in 2027 over 2021.

Region

Introduction

In 2021, North America segment has the highest revenue of US $99.20 million and is expected to grow at CAGR of 8.19% by 2027 North America segment has highest cagr growth of 8.19%.

North America

North America segment was valued at US $83.09 million in 2019 and is projected to grow at 8.19% CAGR over the forecast period to reach US $168.79 million by 2027. North America segment represented US $16.11 million opportunity over 2019-2021 and estimated to create US $69.59 million opportunity in 2027 over 2021.

Europe

Europe segment was valued at US $48.74 million in 2019 and is projected to grow at 8.19% CAGR over the forecast period to reach US $99.01 million by 2027. Europe segment represented US $9.45 million opportunity over 2019-2021 and estimated to create US $40.82 million opportunity in 2027 over 2021.

Asia Pacific

Asia Pacific segment was valued at US $56.71 million in 2019 and is projected to grow at 8.19% CAGR over the forecast period to reach US $115.20 million by 2027. Asia Pacific segment represented US $10.99 million opportunity over 2019-2021 and estimated to create US $47.50 million opportunity in 2027 over 2021.

Rest of the World (Row)

Rest of the World (Row) segment was valued at US $37.34 million in 2019 and is projected to grow at 8.19% CAGR over the forecast period to reach US $75.85 million by 2027. Rest of the World (Row) segment represented US $7.24 million opportunity over 2019-2021 and estimated to create US $31.27 million opportunity in 2027 over 2021.